# Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma

> **NCT06014905** · PHASE1 · RECRUITING · sponsor: **Javier Villaneuva-Meyer, MD** · enrollment: 50 (estimated)

## Conditions studied

- Meningioma

## Interventions

- **DRUG:** Hyperpolarized carbon C 13 pyruvate
- **PROCEDURE:** Magnetic Resonance Image (MRI)
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT06014905
- **Lead sponsor:** Javier Villaneuva-Meyer, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-05-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06014905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06014905, "Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06014905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*